Home › NDC Lookup › RxCUI directory › RxCUI 2689299

LetibotulinumtoxinA-wlbg 50 UNT Injection — RxCUI 2689299

RxNorm drug concept · Semantic clinical drug
RxCUI 2689299 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2689299
Official nameLetibotulinumtoxinA-wlbg 50 UNT Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped2
Package NDCs mapped2
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to OnabotulinumtoxinA Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Botox (onabotulinumtoxinA) has a long list of medical uses that go well beyond cosmetics. It's FDA-approved to treat overactive bladder, prevent chronic migraines, reduce muscle st...
  • I thought Botox was just for wrinkles — what else is it actually used for?
  • The effects typically last several months — the exact duration depends on what you're being treated for. For most conditions, re-injection is done no sooner than every 3 months, an...
  • How long do the effects of Botox last, and how often will I need injections?
📖 Read our full OnabotulinumtoxinA Injection guide →

🕸️ Concept Web — How LetibotulinumtoxinA-wlbg 50 UNT Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept LetibotulinumtoxinA-wlbg 50 UNT Injection RxCUI 2689299

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Botulinum toxin type A 1712
    • LetibotulinumtoxinA-wlbg 2689282
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Letybo 2689291
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Botulinum toxin type A Injection 1732153
    • LetibotulinumtoxinA-wlbg Injection 2689289
    • Botulinum toxin type A Injectable Product 1743429
    • LetibotulinumtoxinA-wlbg Injectable Product 2689288
    • Botulinum toxin type A Injection [Letybo] 2689295
    • LetibotulinumtoxinA-wlbg Injection [Letybo] 2689296
    • Letybo Injectable Product 2689293
    • Injection 1649574
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • LetibotulinumtoxinA-wlbg 50 UNT SCDC · 2689298
  • Botulinum toxin type A Injection SCDF · 1732153
  • LetibotulinumtoxinA-wlbg Injection SCDFP · 2689289
  • Botulinum toxin type A Injectable Product SCDG · 1743429
  • LetibotulinumtoxinA-wlbg Injectable Product SCDGP · 2689288

Brand-Name Concepts

  • LetibotulinumtoxinA-wlbg 50 UNT Injection [Letybo] SBD · 2689301
  • LetibotulinumtoxinA-wlbg 50 UNT [Letybo] SBDC · 2689300
  • Botulinum toxin type A Injection [Letybo] SBDF · 2689295
  • LetibotulinumtoxinA-wlbg Injection [Letybo] SBDFP · 2689296
  • Letybo Injectable Product SBDG · 2689293
  • Letybo BN · 2689291

📦 FDA Products & Package NDCs

2 products · 2 package NDCs
2 package NDCs map to RxCUI 2689299 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
81165-0050-01 1 VIAL, SINGLE-DOSE in 1 CARTON (81165-050-01) / 1 INJECTIO... LETYBO Hugel, Inc. 2024-07-30
81165-0100-01 1 VIAL, SINGLE-DOSE in 1 CARTON (81165-100-01) / 1 INJECTIO... LETYBO Hugel, Inc. 2024-07-30
Observed labelers: Hugel, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.